China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in the People's Republic of China and internationally.
Total Assets Chart for China Resources Sanjiu Medical & Pharmaceutical Co Ltd
China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) total assets for FY2025 were CNY 58.8B, a 46.7% change from FY2024. China Resources Sanjiu Medical & Pharmaceutical Co Ltd's total assets grew from CNY 1.5B in 1997 to CNY 58.8B in 2025 (3906.1% over 28 years). Total assets compound annual growth rate: 5-year CAGR of 21.6%, 10-year CAGR of 17.2%, 20-year CAGR of 11.2%.
Total Assets (CNY)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- ¥40.59B
- Implied Share Price
- ¥24.39
- Enterprise Value
- ¥38.28B
- Revenue (TTM)
- ¥31.81B
- EBITDA
- ¥5.32B
- Profit Margin
- 10.30%
- Trailing P/E
- 12.38
- Forward P/E
- 16.47
- Price/Book (MRQ)
- 1.80
- Price/Sales (TTM)
- 1.28
- EV/EBITDA
- 5.97
- EV/Revenue
- 1.20
- Dividend Yield
- 4.08%
- Book Value
- ¥13.72
- Free Cash Flow (FY2025)
- ¥4.24B
- Free Cash Flow Yield
- 10.45%
Snapshot as of 28th August 2026 — not point-in-time controlled, may lag the live market by a few days.